Details
Ocular Stem Cell Studies
A Comprehensive Overview of Global Clinical Trials|
213,99 € |
|
| Verlag: | Springer |
| Format: | |
| Veröffentl.: | 08.07.2024 |
| ISBN/EAN: | 9783031585579 |
| Sprache: | englisch |
| Anzahl Seiten: | 500 |
Dieses eBook enthält ein Wasserzeichen.
Beschreibungen
<p>This book is a compendium of the worldwide ocular stem cell studies registered with clinicaltrials.gov. The study title is provided, along with the country of origin and the clinical trial number in order to make it easier for the reader to locate the study and obtain further information. An analysis of the type of stem cell utilized and study support is also provided. The final section deals with issues encountered by the stem cell researchers.</p>
<p><em>Ocular Stem Cell Studies: A Comprehensive Overview of Global Clinical Trials</em> is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.</p>
<p> </p>
<p><em>Ocular Stem Cell Studies: A Comprehensive Overview of Global Clinical Trials</em> is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.</p>
<p> </p>
<p><strong>Section 1: Active/Recruiting Studies</strong>.- <strong>Section 1, Part 1: Retina/Optic Nerve</strong>.- Chapter 1: United States.- Chapter 2: Belarus.- Chapter 3: Caribbean/Latin America.- Chapter 4: China.- Chapter 5: Great Britain.- Chapter 6: Indonesia.- Chapter 7: Japan.- Chapter 9: Turkey.- <strong>Section 1, Part 2: Anterior Segment</strong>.- Chapter 10: United States.- Chapter 11: Canada.- Chapter 12: China.- Chapter 13: France.- Chapter 14: Spain.- <strong>Section 2: Active, Non-recruiting Studies</strong>.- <strong>Section 2, Part 1: Retina/Optic Nerve</strong>.- Chapter 15: United States.- Chapter 16: No Location.- <strong>Section 2, Part 2: Anterior Segment</strong>.- Chapter 17: United States.- Chapter 18: Germany.- Chapter 19: Denmark.- Chapter 20: France.- Chapter 21: Spain.- <strong>Section 3: Completed Studies</strong>.- <strong>Section 3, Part 1: Retina/Optic Nerve</strong>.- Chapter 22: United States.- Chapter 23: Brazil.- Chapter 24: Turkey.- <strong>Section 3, Part 2: Anterior Segment</strong>.- Chapter 25: United States.- Chapter 26: Belarus.- Chapter 27: Iran.- Chapter 28: Korea.- Chapter 29: Spain.- <strong>Section 4: Unknown Status</strong>.- Chapter 30: Belgium.- Chapter 31: Brazil.- Chapter 32: China.- Chapter 33: Egypt.- Chapter 34: India.- Chapter 35: Jordan.- Chapter 36: Korea.- Chapter 37: Lebanon.- Chapter 38: Malaysia.- Chapter 39: Poland.- Chapter 40: Spain.- Chapter 41: Taiwan.- Chapter 42: Thailand.- <strong>Section 5: Withdrawn Studies</strong>.- Chapter 43: United States.- Chapter 44: China.- <strong>Section 6: Terminated Studies</strong>.- Chapter 45: United States.- Chapter 46: Iran.- <strong>Section 7: Suspended Studies</strong>.- Chapter 47: Singapore.- <strong>Section 8: Analysis</strong>.- Chapter 48: Analysis of studies.- Chapter 49: Comments. </p><p><br></p>
<p>Jeffrey N. Weiss, M.D., is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology. </p><p><br></p><p>Dr. Weiss is the author of more than 100 publications, including 20 books, holds more than 20 U.S. and foreign patents and has been a Reviewer for multiple scholarly journals. He has served as a Visiting Professor, performed surgery, and lectured both nationally and internationally. Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc., which have manufactured and sold Dr. Weiss’ inventions worldwide. </p><p><br></p><p>Dr. Weiss was the first to invent the equipment and develop the technique to safely perform retinal vessel cannulation. This surgery remains the only option for patients with severe stroke in the eye. He was also the first to report the use of hyperbaric oxygen treatment to successfully treat dry age-related macular degeneration and longer standing central retinal artery occlusions. </p><p><br></p><p>Dr. Weiss performed the first retinal stem cell surgery in 2010, and is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world, and The Neurologic Stem Cell Treatment Study. The studies are Institutional Review Board (IRB) approved, registered with NIH, and listed on ClinicalTrials.gov. </p><p><br></p>
<p>This book is a compendium of the worldwide ocular stem cell studies registered with clinicaltrials.gov. The study title is provided, along with the country of origin and the clinical trial number in order to make it easier for the reader to locate the study and obtain further information. An analysis of the type of stem cell utilized and study support is also provided. The final section deals with issues encountered by the stem cell researchers.</p>
<p><em>Ocular Stem Cell Studies: A Comprehensive Overview of Global Clinical Trials</em> is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.</p>
<p><em>Ocular Stem Cell Studies: A Comprehensive Overview of Global Clinical Trials</em> is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.</p>
Offers a comprehensive overview of the current evidence on clinical trials in the field of ocular stem cell studies The first book to provide coverage on ocular stem cell studies around the world Covers active studies as well as completed, withdrawn, and terminated studies
Diese Produkte könnten Sie auch interessieren:
El ABC de la dermatología 2017
von: Gabriela Frías Ancona, Gabriela Frías Editorial Alfil, S. A. de C. V.
19,99 €
El ABC de los protocolos de infertilidad 2019
von: Rodrigo Ayala Yáñez, Gerardo Barroso Villa, Alejandra Alexia Alvarez Lozano, Alejandra Alexia Alvarez Editorial Alfil, S. A. de C. V.
18,99 €
Neurociencia, neuroética y biética
von: Gabino Uríbarri Bilbao, Adela Cortina Orts, Mónica Triviño Mosquera, Javier de la Torre Díaz
6,99 €
